BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24552865)

  • 1. Profile of idiosyncratic drug induced liver injury in Latin America: an analysis of published reports.
    Hernández N; Bessone F; Sánchez A; di Pace M; Brahm J; Zapata R; A Chirino R; Dávalos M; Méndez-Sánchez N; Arrese M; Schinoni M; Lucena MI; Andrade RJ
    Ann Hepatol; 2014; 13(2):231-9. PubMed ID: 24552865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serious liver injury induced by Nimesulide: an international collaborative study.
    Bessone F; Hernandez N; Mendizabal M; Ridruejo E; Gualano G; Fassio E; Peralta M; Fainboim H; Anders M; Tanno H; Tanno F; Parana R; Medina-Caliz I; Robles-Diaz M; Alvarez-Alvarez I; Niu H; Stephens C; Colombato L; Arrese M; Reggiardo MV; Ono SK; Carrilho F; Lucena MI; Andrade RJ
    Arch Toxicol; 2021 Apr; 95(4):1475-1487. PubMed ID: 33759010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative.
    Bessone F; Hernandez N; Lucena MI; Andrade RJ;
    Int J Mol Sci; 2016 Feb; 17(3):313. PubMed ID: 26938524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication.
    Licata A; Calvaruso V; Cappello M; Craxì A; Almasio PL
    Dig Liver Dis; 2010 Feb; 42(2):143-8. PubMed ID: 19625223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib-induced Liver Injury: Analysis of Published Case Reports and Cases Reported to the Food and Drug Administration.
    Mukthinuthalapati PK; Fontana RJ; Vuppalanchi R; Chalasani N; Ghabril M
    J Clin Gastroenterol; 2018 Feb; 52(2):114-122. PubMed ID: 28795997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced liver injury.
    Leise MD; Poterucha JJ; Talwalkar JA
    Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network.
    Bessone F; García-Cortés M; Medina-Caliz I; Hernandez N; Parana R; Mendizabal M; Schinoni MI; Ridruejo E; Nunes V; Peralta M; Santos G; Anders M; Chiodi D; Tagle M; Montes P; Carrera E; Arrese M; Lizarzabal MI; Alvarez-Alvarez I; Caballano-Infantes E; Niu H; Pinazo J; Cabello MR; Lucena MI; Andrade RJ
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e548-e563. PubMed ID: 33434654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver.
    Bessone F; Hernandez N; Tagle M; Arrese M; Parana R; Méndez-Sánchez N; Ridruejo E; Mendizabal M; Dagher L; Contreras F; Fassio E; Pessoa M; Brahm J; Silva M
    Ann Hepatol; 2021; 24():100321. PubMed ID: 33609753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review: ibuprofen-induced liver injury.
    Zoubek ME; Lucena MI; Andrade RJ; Stephens C
    Aliment Pharmacol Ther; 2020 Mar; 51(6):603-611. PubMed ID: 31984540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period.
    Baekdal M; Ytting H; Skalshøi Kjær M
    Scand J Gastroenterol; 2017 Apr; 52(4):450-454. PubMed ID: 27973926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics and clinical outcome of drug-induced liver injury: a single-center experience.
    Idilman R; Bektas M; Cinar K; Toruner M; Cerit ET; Doganay B; Erden E; Bozkaya H; Bahar K; Karayalcin S; Soykan I; Palabiyikoglu M; Cetinkaya H; Yurdaydin C; Dokmeci A; Ozden A
    J Clin Gastroenterol; 2010 Jul; 44(6):e128-32. PubMed ID: 20551776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy.
    Donati M; Conforti A; Lenti MC; Capuano A; Bortolami O; Motola D; Moretti U; Vannacci A; Rafaniello C; Vaccheri A; Arzenton E; Bonaiuti R; Sportiello L; Leone R;
    Br J Clin Pharmacol; 2016 Jul; 82(1):238-48. PubMed ID: 26991794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry.
    Björnsson ES; Stephens C; Atallah E; Robles-Diaz M; Alvarez-Alvarez I; Gerbes A; Weber S; Stirnimann G; Kullak-Ublick G; Cortez-Pinto H; Grove JI; Lucena MI; Andrade RJ; Aithal GP
    Liver Int; 2023 Jan; 43(1):115-126. PubMed ID: 35899490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of drug-induced liver injury as etiology for acute liver failure in Brazil.
    Santos G; Figueira ERR; D'Albuquerque LAC; Lisboa PB; de Almeida MD; Filgueira NA; Boin I; Porta G; da Silva RCMA; Viana CFG; Faria LC; Alvares-da-Silva MR; de Moraes ACP; Morsoletto DBG; Codes L; Paraná R
    Ann Hepatol; 2021; 23():100310. PubMed ID: 33508520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions and organ damage: The liver.
    Licata A
    Eur J Intern Med; 2016 Mar; 28():9-16. PubMed ID: 26827101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Prevalence of Ibuprofen Drug-Induced Liver Injury in Spanish and Latin-American Registries.
    Zoubek ME; González-Jimenez A; Medina-Cáliz I; Robles-Díaz M; Hernandez N; Romero-Gómez M; Bessone F; Hallal H; Cubero FJ; Lucena MI; Stephens C; Andrade RJ
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):292-294. PubMed ID: 28782674
    [No Abstract]   [Full Text] [Related]  

  • 18. Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry.
    Rao A; Rule JA; Hameed B; Ganger D; Fontana RJ; Lee WM
    Am J Gastroenterol; 2022 Apr; 117(4):617-626. PubMed ID: 35081550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review.
    Niu H; Atallah E; Alvarez-Alvarez I; Medina-Caliz I; Aithal GP; Arikan C; Andrade RJ; Lucena MI
    Drug Saf; 2022 Nov; 45(11):1329-1348. PubMed ID: 36006605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
    Medina-Caliz I; Garcia-Cortes M; Gonzalez-Jimenez A; Cabello MR; Robles-Diaz M; Sanabria-Cabrera J; Sanjuan-Jimenez R; Ortega-Alonso A; García-Muñoz B; Moreno I; Jimenez-Perez M; Fernandez MC; Ginés P; Prieto M; Conde I; Hallal H; Soriano G; Roman E; Castiella A; Blanco-Reina E; Montes MR; Quiros-Cano M; Martin-Reyes F; Lucena MI; Andrade RJ;
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1495-1502. PubMed ID: 29307848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.